CIK 0001810560 · Non-accelerated filer<br>Smaller reporting company
REVELATION BIOSCIENCES, INC.
Sign in to watch- Ticker
- REVB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 843898466
- Phone
- 650-800-3717
- Business address
- 4660 LAJOLLA VILLAGE DRIVE, SUITE 100, SAN DIEGO, CA, 92122
- Former names
- Petra Acquisition Inc.
Securities
- REVB Common Stock Nasdaq
- REVBW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-10-16 | TYPALDOS ANDREAS Chief Executive Officer | Other acquisition · Redeemable Warrant | +83,446 | $1.00 | $83K | 3,233,446 |
| 2020-10-16 | Fitzpatrick Sean H Chief Financial Officer | Other acquisition · Redeemable Warrant | +83,446 | $1.00 | $83K | 3,233,446 |
| 2020-10-12 | GLAZER CAPITAL, LLC 10% owner | Sale | −20 | $10.00 | $200 | 1,040,652 |
| 2020-10-09 | GLAZER CAPITAL, LLC 10% owner | Sale | −9,328 | $10.00 | $93K | 1,040,672 |
Page 4 of 4 · 64 trades